Sponsored by ASLAN PharmaceuticalsIn this video series, Peter Lio, MD, sheds new light on the current and future state of atopic dermatitis treatments from the patient viewpoint – highlighting qualitative and quantitative findings.
EP. 1: Patient Viewpoints: Qualitative Research “One-on-ones”
Peter Lio, MD, explores the impact of atopic dermatitis on patient quality of life and how it shapes current and future treatment satisfaction.
EP. 2: Patient Viewpoints: Quantitave Research
Peter Lio, MD, shares findings and takeaways from a quantitative study designed to spotlight patient perceptions of current atopic dermatitis treatments and willingness to try new therapies.
EP. 3: The Crystal Ball: What This Means for the Future of Atopic Dermatitis Treatments
Peter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.
Compound Heparin Sodium Allantoin Gel Can Treat Rosacea and Improve Skin Barrier
New Study Sheds Light on Vitiligo-CHD Association
Topical Antioxidants Combined with Phototherapy Effective for Vitiligo Management
Attovia Closes $90 Million Series C Financing for ATTOBODY Programs